CLINICAL IMPORTANCE OF HEPATIC CYTOCHROME-P450 IN DRUG-METABOLISM

被引:224
作者
SPATZENEGGER, M [1 ]
JAEGER, W [1 ]
机构
[1] UNIV VIENNA,INST PHARMACEUT CHEM,A-1090 VIENNA,AUSTRIA
关键词
D O I
10.3109/03602539508998329
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:397 / 417
页数:21
相关论文
共 143 条
  • [1] THE PHARMACOKINETICS OF ONDANSETRON AFTER INTRAVENOUS-INJECTION IN HEALTHY-VOLUNTEERS PHENOTYPED AS POOR OR EXTENSIVE METABOLIZERS OF DEBRISOQUINE
    ASHFORTH, EIL
    PALMER, JL
    BYE, A
    BEDDING, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (04) : 389 - 391
  • [2] INVIVO EVIDENCE THAT ETHOSUXIMIDE IS A SUBSTRATE FOR CYTOCHROME-P450IIIA
    BACHMANN, K
    CHU, CA
    GREEAR, V
    [J]. PHARMACOLOGY, 1992, 45 (03) : 121 - 128
  • [3] INDUCTION OF CYTOCHROME-P450 AND PEROXISOMAL ENZYMES BY CLOFIBRIC ACID INVIVO AND INVITRO
    BARS, RG
    BELL, DR
    ELCOMBE, CR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) : 2045 - 2053
  • [4] EFFECT OF CYTOCHROME-P-450 1A INDUCTION ON ENANTIOSELECTIVE METABOLISM AND PHARMACOKINETICS OF AN ARYLTRIFLUOROMETHYL SULFIDE IN THE RAT
    BENOIT, E
    BURONFOSSE, T
    DELATOUR, P
    [J]. CHIRALITY, 1994, 6 (05) : 372 - 377
  • [5] BERSON A, 1993, J PHARMACOL EXP THER, V265, P366
  • [6] BOELSTERLI UA, 1992, DRUG METAB DISPOS, V20, P96
  • [7] BOLAJI OO, 1993, RES COMMUN CHEM PATH, V82, P111
  • [8] BORNHEIM LM, 1992, DRUG METAB DISPOS, V20, P241
  • [9] BOTSCH S, 1993, MOL PHARMACOL, V43, P120
  • [10] BOURDI M, 1992, MOL PHARMACOL, V42, P280